SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Reed Cappleman, Ian Smith, Fiona Lobban, Managing bipolar moods without medication: A qualitative investigation, Journal of Affective Disorders, 2015, 174, 241

    CrossRef

  2. 2
    Suresh Durgam, Anju Starace, Dayong Li, Raffaele Migliore, Adam Ruth, György Németh, István Laszlovszky, The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial, Bipolar Disorders, 2015, 17, 1
  3. 3
    Terence A. Ketter, Shefali Miller, Bernardo Dell'Osso, Joseph R. Calabrese, Mark A. Frye, Leslie Citrome, Balancing benefits and harms of treatments for acute bipolar depression, Journal of Affective Disorders, 2014, 169, S24

    CrossRef

  4. 4
    Leslie Citrome, Terence A. Ketter, Josephine Cucchiaro, Antony Loebel, Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed, Journal of Affective Disorders, 2014, 155, 20

    CrossRef

  5. 5
    T. A. Furukawa, How can we make the results of trials and their meta-analyses using continuous outcomes clinically interpretable?, Acta Psychiatrica Scandinavica, 2014, 130, 5
  6. 6
    Shaun Yon-Seng Khoo, Robyn Mary Brown, Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?, CNS Drugs, 2014, 28, 8, 713

    CrossRef

  7. 7
    Ludovic Samalin, Aurore Tremey, Pierre-Michel Llorca, Quetiapine extended release for the treatment of bipolar disorder, Expert Review of Neurotherapeutics, 2014, 14, 9, 987

    CrossRef

  8. 8
    Leslie Citrome, Treatment of bipolar depression: making sensible decisions, CNS Spectrums, 2014, 19, S1, 1

    CrossRef

  9. 9
    Leslie Citrome, Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy, Advances in Therapy, 2013, 30, 2, 102

    CrossRef

  10. 10
    Trisha Suppes, Terence A. Ketter, Iola S. Gwizdowski, Ellen B. Dennehy, Shelley J. Hill, E. Grace Fischer, Diane E. Snow, Robert Gonzalez, Suresh Sureddi, Geetha Shivakumar, Victoria E. Cosgrove, First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo, Journal of Affective Disorders, 2013, 150, 1, 37

    CrossRef

  11. 11
    Leslie Citrome, Terence A. Ketter, Number needed to treat can be helpful: A response to Alphs et al., European Neuropsychopharmacology, 2013, 23, 11, 1656

    CrossRef

  12. You have free access to this content12
    L. Citrome, T. A. Ketter, When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed, International Journal of Clinical Practice, 2013, 67, 5
  13. 13
    U. Werneke, M. Ott, E. Salander Renberg, D. Taylor, B. Stegmayr, A decision analysis of long-term lithium treatment and the risk of renal failure, Acta Psychiatrica Scandinavica, 2012, 126, 3
  14. 14
    Gin S Malhi, Danielle M Bargh, Roger McIntyre, Michael Gitlin, Mark A Frye, Michael Bauer, Michael Berk, Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder, Bipolar Disorders, 2012, 14,
  15. 15
    Leslie Citrome, Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 7, 873

    CrossRef

  16. 16
    René Ernst Nielsen, Per Damkier, Pharmacological treatment of unipolar depression during pregnancy and breast-feeding—A clinical overview, Nordic Journal of Psychiatry, 2012, 66, 3, 159

    CrossRef

  17. 17
    Shefali Srivastava, Po W. Wang, Shelley J. Hill, Meredith E. Childers, Kristine L. Keller, Terence A. Ketter, Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients, Journal of Psychiatric Research, 2012, 46, 7, 920

    CrossRef

  18. 18
    Shefali Srivastava, Terence A. Ketter, Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects, Clinical Therapeutics, 2011, 33, 12, B40

    CrossRef

  19. 19
    Leslie Citrome, Olanzapine–fluoxetine combination for the treatment of bipolar depression, Expert Opinion on Pharmacotherapy, 2011, 12, 17, 2751

    CrossRef